|

Piflufolastat Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 18F-DCFPyL, Fluorine F 18 DCFPyL, Piflufolastat F-18, Pylarify

Pipeline

Phase 4: 1

Top Sponsors

  • OHSU Knight Cancer Institute1

Indications

  • Castration Sensitive Prostate Cancer1
  • Castration-resistant Prostate Cancer1
  • Prostate Adenocarcinoma1
  • Cancer1

Portland, Oregon1 trial

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

OHSU Knight Cancer Institute

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.